Quick Hits: Lee, Brewers, Moyer, Bonderman

Giants reliever Guillermo Mota is appealing his 100-game suspension due to a positive drug test, reports Andrew Baggarly of CSNBayArea.com. In a statement issued through Adam Katz, Mota's agent, the right-hander claims that children's cough medicine was responsible for the banned substance (clenbuterol) that was found in his system. Since this is his second drug-related suspension, Mota will not be allowed to continue playing while waiting for an appeal.

Here's the latest from around the majors….

Brewers GM Doug Melvin told Trenni Kusnierek of WTMJ 620 radio in Milwaukee that the team "had a discussion" with free agent first baseman Derrek Lee but a signing is "not going to happen." The team will look internally to fill its hole at first base with Mat Gamel out for the season.

Melvin also said that the Brewers have the financial resources and farm system depth to make trades if necessary, though the club will wait until about a week before the July trade deadline before deciding if any moves need to be made. Melvin predicts less deadline activity in general around baseball this year due to both the Cardinals' late-season hot streak last year and the extra wild card that will have more teams unwilling to give up on their season.

Jamie Moyer thought he had a deal worked out with the Orioles last fall but Dan Duquette's hiring scuttled the move, reports Caleb Hannan of the Denver News. "They said one thing one day and by the next it was completely different," Moyer said. "They pulled a complete 180." One of the reasons may have been due to an incident between Moyer and Duquette in 1996 when both men were with the Red Sox.

Jeremy Bonderman tells Chris Iott of MLive.com that he was "burnt out" and didn't expect to return to baseball when he sat out the 2011 season but he's now eager to pitch again. Bonderman underwent Tommy John surgery last month and is hoping to catch on with a team in 2013.

Teams that write off several seasons in the name of a long rebuilding process run the risk of permanently alienating their fans, writes Geoff Baker of the Seattle Times.